C4 Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -179.4% | -183.2% |
| FY2022 | — | -416.6% | -412.2% |
| FY2023 | — | -669.8% | -638.3% |
| FY2024 | — | -336.1% | -296.0% |
| FY2025 | — | -320.5% | -292.1% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -179.4% | -183.2% |
| FY2022 | — | -416.6% | -412.2% |
| FY2023 | — | -669.8% | -638.3% |
| FY2024 | — | -336.1% | -296.0% |
| FY2025 | — | -320.5% | -292.1% |